Results 251 to 260 of about 8,328,477 (294)

G-HIV: An Integrated Long-Read Sequencing and Automated Bioinformatics Platform for Rapid and Precise HIV-1 Surveillance. [PDF]

open access: yesMicroorganisms
Fu P   +11 more
europepmc   +1 more source

Ensilication preserves high-molecular weight native DNA for clinical long-read sequencing. [PDF]

open access: yesGenome Biol
Ferrasse A   +10 more
europepmc   +1 more source

Prospective clinical validation of targeted long-read sequencing for preimplantation genetic testing of α-thalassaemia. [PDF]

open access: yesReprod Biol Endocrinol
Shi Q   +11 more
europepmc   +1 more source

Targeted long-read sequencing enables comprehensive analysis of the genetic and epigenetic landscape of inherited myopathies. [PDF]

open access: yesNat Commun
Yeow D   +39 more
europepmc   +1 more source

Towards population-scale long-read sequencing [PDF]

open access: yesNature Reviews Genetics, 2021
: Long-read sequencing technologies have now reached a level of accuracy and yield that allows their application to variant detection at a scale of tens to thousands of samples.
Fritz Sedlazeck   +2 more
exaly   +5 more sources

Genomics in the long-read sequencing era

Trends in Genetics, 2023
Long-read sequencing (LRS) technologies have provided extremely powerful tools to explore genomes. While in the early years these methods suffered technical limitations, they have recently made significant progress in terms of read length, throughput, and accuracy and bioinformatics tools have strongly improved.
Claude Thermes   +2 more
exaly   +3 more sources

Iso-Seq Long Read Transcriptome Sequencing

2021
Isoform sequencing (Iso-Seq), a long-read transcriptome sequencing method developed by Pacific Biosciences, has the capacity to generate full-length transcripts without the need for assembly. The method facilitates better genome annotation, identification of alternative splicing events, novel transcript isoforms and epi-transcriptome modification which
Hoang, Nam V., Henry, Robert J.
openaire   +2 more sources

Home - About - Disclaimer - Privacy